600422 KPC Pharmaceuticals, Inc.
- 15.87
- +0.26+1.67%
KPC Pharmaceuticals, Inc. News
KPC Group\'s progress announcement on the acquisition of 51% of Kunming Huarun Shenghuo Pharmaceutical
KPC Group\'s progress announcement on the acquisition of 51% of Kunming Huarun Shenghuo Pharmaceutical
Kunyao Group: Beijing Deheng (Kunming) Law Firm\'s Legal Opinion on the Implementation of Some Restricted Stocks in the 2021 Restricted Stock Incentive Plan for Repurchase and Cancellation of KPC Group Co., Ltd.
Legal opinion of Beijing Deheng (Kunming) Law Firm on the implementation of some restricted stocks in the 2021 Restricted Stock Incentive Plan for Repurchase and Cancellation of Kunming Pharmaceutical Group Co., Ltd.
KPC Group\'s Implementation Notice on Equity Incentive Restricted Stock Repurchase and Cancellation
Donghai Securities Co., Ltd.\'s verification opinion on the overall completion of the public offering fund-raising project of Kunming Pharmaceutical Group Co., Ltd. and the savings raised to permanently supplement working capital
Announcement of KPC Group on the overall completion of the public offering of fund-raising projects and permanently supplementing working capital with the savings raised
Notice of Implementation of Annual Equity Distribution of KPC Pharmaceuticals, Inc. in 2023
KPC Pharmaceuticals, Inc. announcement regarding repurchase and cancellation of restricted stocks and notifying creditors.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. intends to transfer a 51% stake in Kunming China Resources Shenghuo Pharmaceutical Co., Ltd. to KPC Pharmaceuticals, Inc. Asset evaluation report of the project.
Announcement of kpc pharmaceuticals, inc. Acquisition of 51% equity of Kunming CR Sanjiu Pharmaceutical Co., Ltd. and related transactions.
Announcement of KPC Pharmaceuticals, Inc.'s buyback and cancellation of the 2021 restricted stock incentive plan, which has been granted but the restricted stocks have not yet been released.
Legal opinion of Beijing Deheng (Kunming) Law Firm on the repurchase and cancellation of restricted stocks of KPC Pharmaceuticals, Inc.'s 2021 restricted stock incentive plan.
Announcement of KPC on 2023 Profit Distribution Plan
Legal opinion of Beijing Deheng (Kunming) Law Firm on the implementation of some restricted stocks in the 2021 Restricted Stock Incentive Plan for Repurchase and Cancellation of Kunming Pharmaceutical Group Co., Ltd.
Kunming Pharmaceutical Group Announcement on the Implementation of Equity Incentives and Cancellation of Restricted Stock Repurchase
KPC Group\'s Notice to Creditors on Repurchase and Cancellation of Some Restricted Shares
Kunyao Group\'s announcement on the repurchase and cancellation of the 2021 Restricted Stock Incentive Plan for leaving employment incentives that have been granted but the restrictions on sale of some restricted stocks have not yet been lifted
Legal opinion of Beijing Deheng (Kunming) Law Firm on Kunming Pharmaceutical Group Co., Ltd.\'s repurchase and cancellation of some restricted stocks in the 2021 restricted stock incentive plan
Announcement of Kunming Pharmaceutical Group to Notify Creditors of Repurchase and Cancellation of Certain Restricted Shares
No Data